Impeto Medical
Impeto Medical develops a non-invasive technology that analyzes the activities of sweat glands to detect early stages of diabetes..
Launch date
Employees
Market cap
-
Enterprise valuation
$27—40m (Dealroom.co estimates Jan 2011.)
Company register number 482837366
Paris Île-de-France (HQ)
Financials
Estimates*
EUR | 2015 |
---|---|
Revenues | 5.6m |
EBITDA | <1m |
% EBITDA margin | 5 % |
Profit | <1m |
% profit margin | 1 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
€6.1m | Early VC | ||
€5.7m | Debt | ||
* | N/A | Acquisition | |
Total Funding | $6.7m |
Recent News about Impeto Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.